Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Niveau de preuve du suivi thérapeutique pharmacologique du 5-fluorouracile au décours de son administration dans le traitement des cancers des voies aérodigestives supérieures et du cancer colorectal

Michèle Boisdron-Celle, Chantal Le Guellec

Therapie, 65 3 (2010) 171-176

Published online: 2010-08-11

DOI: https://doi.org/10.2515/therapie/2010023

This article has been cited by the following article(s):

Molecular relation between biological stress and carcinogenesis

Katarzyna Rakoczy, Wojciech Szlasa, Natalia Sauer, Jolanta Saczko and Julita Kulbacka
Molecular Biology Reports 49 (10) 9929 (2022)
https://doi.org/10.1007/s11033-022-07543-6

How can we best monitor 5-FU administration to maximize benefit to risk ratio?

Françoise Goirand, Florian Lemaitre, Manon Launay, et al.
Expert Opinion on Drug Metabolism & Toxicology 14 (12) 1303 (2018)
https://doi.org/10.1080/17425255.2018.1550484

Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer

Florian Lemaitre, Françoise Goirand, Manon Launay, et al.
Bulletin du Cancer 105 (9) 790 (2018)
https://doi.org/10.1016/j.bulcan.2018.06.008

LC‐MS/MS method for simultaneous analysis of uracil, 5,6‐dihydrouracil, 5‐fluorouracil and 5‐fluoro‐5,6‐dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients

Barbara Büchel, Peter Rhyn, Stefan Schürch, Claudia Bühr, Ursula Amstutz and Carlo R. Largiadèr
Biomedical Chromatography 27 (1) 7 (2013)
https://doi.org/10.1002/bmc.2741

Adaptation posologique du 5Fluorouracile (5FU) dans le cas d’un déficit en dihydropyrimidine déshydrogénase (DPD)

D. Uge, A. Petitcollin, D. Boulay, D. Baetz and J. Grassin
Le Pharmacien Hospitalier et Clinicien 47 S72 (2012)
https://doi.org/10.1016/j.phclin.2011.12.174